Buy Crypto Markets Spot FuturesBTC Earn Event Centre Rewards Hub

Relay Therapeutics, Inc. (RLAY)

NASDAQ

$19.00

$+0.23

(+1.25%)

Pre-Market

Relay Therapeutics, Inc. (RLAY) Live Price Chart

Last updated: ⁦2026-09-16 10:31:40⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Relay Therapeutics, Inc. (RLAY) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $19.00, with a market capitalisation of $4.18B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $4.05 to $21.27. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$4.18B
Open	$18.77
Day's High	$64.37
Day's Low	$1.78
Previous Close	$18.97
Volume	413.00
Average Volume	3.19M
P/E Ratio	--
52-Week High	$21.27
52-Week Low	$4.05
Dividend Yield	--
Earnings Date	--

Relay Therapeutics, Inc. (RLAY) Pre-Market Stock Price

Relay Therapeutics, Inc. (RLAY) is trading at $19.00 in pre-market trading as of 2026-09-16 09:49:00, up 0.16% ($0.03) from the previous close of $18.97

Pre-market trading shows how investors are pricing RLAY before the regular session opens. The current pre-market price is near the previous close, indicating positive early trading sentiment.

Relay Therapeutics, Inc. (RLAY) 7-Day Stock Price Change

Over the past seven days, Relay Therapeutics, Inc. (RLAY) moved from $19.04 to $19.00, representing a decline of 0.21% ($0.04).

The stock traded between $18.10 and $19.43 during the period. The latest price is near the upper end of the 7-day range, indicating range-bound.

The average daily volume was 3.64 million shares, up versus the previous seven-day period, indicating higher trading activity.

RLAY 52-Week Price Position

Position in Range: 86.8%

52W Low$4.05

52W High$21.27

RLAY is currently trading at $19.00, placing it 86.8% of the way from its 52-week low of $4.05 to its 52-week high of $21.27. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Relay Therapeutics, Inc. (RLAY)?

Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients. The Dynamo platform of the company integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-8186, RLY-2608, RLY-4008 and others.

Relay Therapeutics, Inc. Information

Industry	BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees	192
Exchange	NASDAQ
Company Website	https://www.relaytx.com

How to Buy Relay Therapeutics, Inc. (RLAY) Stock on MEXC

Eligible investors can buy real shares of Relay Therapeutics, Inc. (RLAY) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for RLAY and Place Your Order

Open the RealStocks trading page and search for RLAY. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Relay Therapeutics, Inc. (RLAY) stock price today?

Relay Therapeutics, Inc. (RLAY) is currently trading at $ 19.00, up 0.16% ($0.03) from the previous close of $ 18.97. Intraday prices update in real time during regular trading hours.

2.Is RLAY stock going up or down today?

As of 2026-09-16 09:49:00, RLAY is trading at $ 19.00, up 0.16% ($0.03) from its previous close of $ 18.97. The stock has traded between $ 1.78 and $ 64.37 during today’s regular session. Past price movements do not guarantee future results.

3.What is RLAY pre-market price?

As of 2026-09-16 09:49:00, RLAY is trading at $ 19.00 in pre-market trading, up 0.16% ($0.03) from the previous close of $ 18.97. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is RLAY after-hours price?

As of 2026-09-16 09:49:00, RLAY is trading at $ 18.77 in after-hours trading, down 1.06% ($0.20) from the regular-session close of $ 18.97. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is RLAY stock trading now?

RLAY trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does RLAY sit relative to its 52-week high and low?

Over the past 52 weeks, RLAY has traded between a low of $ 4.05 and a high of $ 21.27. At $ 19.00, the stock is positioned 86.8% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Relay Therapeutics, Inc. in?

Relay Therapeutics, Inc. (RLAY) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Relay Therapeutics, Inc.'s market capitalisation and where is it listed?

Relay Therapeutics, Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 4.18B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is RLAY valued in terms of P/E ratio and EPS?

RLAY trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -1.31. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Relay Therapeutics, Inc. pay a dividend?

Relay Therapeutics, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.